On January 22, 2026, the U.S. formally withdrew from the World Health Organization (WHO) after a yearlong process initiated by President Trump. The decision stems from the WHO's handling of the COVID-19 pandemic, particularly its delay in declaring a global health emergency and its perceived political influence, especially from China. The U.S. Department of Health and Human Services and the Department of State cited the organization's failure to adopt meaningful reforms and its inability to act independently from member states' political pressures.

This withdrawal marks a significant shift in global public health governance. The U.S., traditionally a leading force in global health, will now prioritize direct bilateral engagements over its cooperation with the WHO. The move highlights ongoing tensions between scientific institutions and national governments over pandemic response strategies and transparency. Critics argue that the U.S. exit could weaken global health coordination, while supporters believe it will allow the U.S. to act more swiftly and independently in health crises.

Looking ahead, the U.S. plans to continue its global health leadership through new engagements with countries, private sectors, and non-governmental organizations. This pivot could reshape how international health efforts are coordinated and funded, potentially setting a new precedent for global health governance. The impact on ongoing health initiatives and future pandemic responses remains to be seen, as does the WHO's ability to adapt and regain trust in the absence of U.S. participation.